Using a syngeneic mouse model of breast cancer, here, we found that SRC-3 inhibition by SI-2 treatment and SRC-3 knockdown generated tumor-suppressing TIME by recruiting cytotoxic immune cells changing through Cxcl9 elevation in breast tumors to aid in the suppression of breast tumor progression. This evidence concerns the gene CXCL9 and breast neoplasm.